Stock Selection: Perplexity's picks for 2026-11-02
Perplexity picked RIVN, MAR, IDXX, REGN, GPN for a 1-day horizon. Portfolio return vs SPY: +1.86%. Picks that beat SPY: 80%.
| Experiment | Stock Selection |
|---|---|
| Model | Perplexity |
| Prompt version | stock-selection-v8 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-11-02 |
| Measured to | 2026-11-03 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | +1.86% |
| Picks that beat SPY | 80% |
| Benchmark return | -0.98% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | RIVN | -1.55% | 68% | -0.57% | No |
| 2 | MAR | +1.55% | 64% | +2.53% | Yes |
| 3 | IDXX | +4.38% | 62% | +5.36% | Yes |
| 4 | REGN | +0.29% | 60% | +1.28% | Yes |
| 5 | GPN | -0.28% | 55% | +0.70% | Yes |
The model's market view
US equities are rebounding after Friday's sharp AI/technology-led selloff, with falling oil prices, stabilizing megacap technology, and strong company-specific earnings catalysts supporting a risk-on intraday tone. I favor stocks with fresh positive earnings or corporate-action catalysts over broad AI exposure, while acknowledging that midterm-election and macro headlines could revive volatility.
Why each pick
RIVN
Rivian is the highest-conviction one-day momentum pick: UBS upgraded the shares to Buy with a $17 target, citing an attractive entry point after a roughly 19% one-month decline, solid initial R2 SUV demand, and an expected path to positive automotive gross margin. The stock opened sharply higher and was trading around $13.05 intraday, well above the prior close. Risks: the move may mean-revert after the initial pop, and Rivian remains a volatile, unprofitable EV maker sensitive to sentiment and execution concerns.
MAR
Marriott rallied about 5.5% after reporting better-than-expected quarterly profits and strength across its global hotels business. With travel demand holding up and the stock benefiting from a clear earnings catalyst rather than the crowded AI trade, it has a credible path to continue outperforming SPY through the session. The latest intraday quote found was $400.98, up 1.67%; earlier premarket quotes were higher, so the reference price is an intraday delayed quote. Risks: post-earnings gains can fade, and a broad market reversal or renewed oil-price spike could pressure discretionary travel names.
IDXX
IDEXX Laboratories surged roughly 16-18% after strong Q3 results, with revenue and EPS beating expectations and a major positive earnings reaction. The stock was trading near $654.67 intraday, near its session high, and its defensive veterinary-diagnostics profile makes it less exposed to the AI/semiconductor selloff that hurt SPY's technology weighting. Risks: the move is already very large, leaving the stock vulnerable to profit-taking; any guidance disappointment or sector rotation could quickly erase part of the gain.
REGN
Regeneron jumped 13.33% on strong Q3 earnings, higher revenue, and a newly announced dividend, providing a fundamental catalyst and defensive biotech exposure during a technology-led market rebound. It traded around $959.50 at 10:10 a.m. ET, extending the earnings-driven advance. Risks: the initial move is substantial and biotech can be sensitive to drug-pipeline, regulatory, or political headlines; a broader risk-off reversal could limit follow-through.
GPN
Global Payments is higher on reports that CD&R and GTCR are pursuing a potential take-private deal, a discrete corporate-action catalyst that can sustain intraday interest independent of the AI trade. It traded around $97.55 intraday, up 0.73%, after a much larger prior-session move. Risks: takeover speculation may not be confirmed, and if deal enthusiasm fades the stock could give back gains; it also carries integration and leverage risk if a transaction proceeds.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| GPT-6.1 Sol | DAL, MAR, NVDA, AVGO, IDXX | +2.17% | 100% |
| GPT-6 | MAR, UAL, IDXX, XPEV, PLTR | +0.05% | 60% |
| Claude Opus 5.5 | MAR, EL, SMH, MU, UAL | +0.02% | 40% |
| Claude Sonnet 5.5 | AMD, NVDA, PLTR, AMZN, DAL | -1.58% | 40% |
| Muse Spark 1.1 | TSLA, NVDA, PLTR, QQQ, AAPL | -2.23% | 20% |
| Gemini 3 Pro | UAL, CCL, DAL, VRT, XLI | +0.63% | 60% |
| Grok 4.7 | IDXX, RIVN, ULCC, NVDA, JBLU | -0.31% | 60% |
| DeepSeek | OKTA, AAPL, QQQ, PLTR, RIVN | -2.77% | 0% |
Written up on ForecastNest Insights: Stock Selection: Perplexity's picks for 2026-11-02.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.